RJA
NTNX icon

Raymond James & Associates’s Nutanix NTNX Stock Holding History

Raymond James & Associates’s Portfolio NTNX Stock Details NTNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$3.29M Sell
55,563
-6,370
-10% -$350K ﹤0.01% 1910
2024
Q2 		$3.52M Sell
61,933
-4,109
-6% -$252K ﹤0.01% 1820
2024
Q1 		$4.08M Sell
66,042
-7,723
-10% -$445K ﹤0.01% 1731
2023
Q4 		$3.52M Buy
73,765
+55,596
+306% +$2.25M ﹤0.01% 1753
2023
Q3 		$634K Sell
18,169
-1,035
-5% -$32.5K ﹤0.01% 2738
2023
Q2 		$539K Sell
19,204
-2,678
-12% -$71.1K ﹤0.01% 2893
2023
Q1 		$569K Sell
21,882
-1,741
-7% -$47.1K ﹤0.01% 2840
2022
Q4 		$615K Sell
23,623
-2,479
-9% -$67.7K ﹤0.01% 2747
2022
Q3 		$544K Sell
26,102
-6,479
-20% -$118K ﹤0.01% 2809
2022
Q2 		$477K Sell
32,581
-5,391
-14% -$112K ﹤0.01% 2947
2022
Q1 		$1.02M Sell
37,972
-2,161
-5% -$57.9K ﹤0.01% 2582
2021
Q4 		$1.28M Sell
40,133
-61,324
-60% -$2.1M ﹤0.01% 2465
2021
Q3 		$3.83M Sell
101,457
-127,179
-56% -$4.81M ﹤0.01% 1675
2021
Q2 		$8.74M Sell
228,636
-794
-0.3% -$24.7K 0.01% 1149
2021
Q1 		$6.09M Sell
229,430
-74,304
-24% -$2.26M 0.01% 1302
2020
Q4 		$9.68M Sell
303,734
-24,831
-8% -$674K 0.01% 971
2020
Q3 		$7.29M Buy
328,565
+9,971
+3% +$228K 0.01% 1024
2020
Q2 		$7.55M Buy
318,594
+12,814
+4% +$265K 0.01% 967
2020
Q1 		$4.83M Buy
305,780
+72,232
+31% +$2.03M 0.01% 1073
2019
Q4 		$7.3M Sell
233,548
-78,432
-25% -$2.32M 0.01% 1050
2019
Q3 		$8.19M Sell
311,980
-14,918
-5% -$352K 0.01% 959
2019
Q2 		$8.48M Buy
326,898
+86,902
+36% +$3.03M 0.01% 942
2019
Q1 		$9.06M Buy
239,996
+38,685
+19% +$1.77M 0.01% 874
2018
Q4 		$8.37M Buy
201,311
+82,376
+69% +$3.4M 0.01% 843
2018
Q3 		$5.08M Buy
118,935
+4,259
+4% +$225K 0.01% 1209
2018
Q2 		$5.91M Buy
114,676
+84,158
+276% +$4.63M 0.01% 1091
2018
Q1 		$1.5M Sell
30,518
-51,130
-63% -$2.03M ﹤0.01% 1873
2017
Q4 		$2.88M Sell
81,648
-52,648
-39% -$1.6M 0.01% 1450
2017
Q3 		$3.01M Buy
134,296
+117,241
+687% +$2.56M 0.01% 1359
2017
Q2 		$344K Buy
+17,055
New +$298K ﹤0.01% 2646
2017
Q1 		– Sell
-31,003
Closed -$823K – 3359
2016
Q4 		$823K Buy
+31,003
New +$924K ﹤0.01% 2042

Other funds holding NTNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Raymond James & Associates's NTNX Position: Q3 2024 in Review

Raymond James & Associates reduced its Nutanix (NTNX) stake by 10% in Q3 2024, selling an estimated $350K and leaving 55,563 shares worth $3.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1910.

Raymond James & Associates first reported a position in NTNX in Q4 2016 and has held it in 31 quarters since. The position peaked at $9.68M in Q4 2020. 478 funds tracked by Wall St. Rank hold NTNX as of Q3 2024.

  • Raymond James & Associates held 55,563 shares of Nutanix worth $3.29M as of Q3 2024.
  • Raymond James & Associates sold 6,370 Nutanix shares in Q3 2024, an estimated $350K.
  • Nutanix made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1910 holding.
  • Raymond James & Associates first reported a position in Nutanix in Q4 2016 and has held it in 31 quarters since.
  • Raymond James & Associates's Nutanix position peaked at $9.68M in Q4 2020.
  • 478 funds tracked by Wall St. Rank held Nutanix as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.